Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its ...

A team of researchers from NUS has developed a novel method to enhance the precision of cancer treatment using gold ...

The "In Vivo CRO Market Size, Share & Trends Analysis Report By Model Type, By Modality, By Indication, By GLP Type, By ...

Many cancers upregulate an amino acid transporter to fuel their growth, making this protein a promising tool in tumor ...

Melanoma, one of the most aggressive forms of skin cancer, often metastasizes to bones, causing severe bone loss, an increased risk of fractures, and significant pain.

Oxford Drug Design has reported positive results from an in vivo colorectal cancer model study on mice, which, it said, ...

Rakesh Jain Ph.D., Director of the E.L. Steele Laboratories for Tumor Biology at Massachusetts General Hospital and A. Werk Cook Professor of Radiation Oncology at Harvard Medical School, is senior ...